Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study

Qian Guo, Yuchen Zheng, Jia Shi, Jijun Wang, Guanjun Li, Chunbo Li, John A Fromson, Yong Xu, Xiaohua Liu, Hua Xu, Tianhong Zhang, Yunfei Lu, Xiaorong Chen, Hao Hu, Yingying Tang, Shuwen Yang, Han Zhou, Xiaoliang Wang, Haiying Chen, Zhen Wang, Zongguo Yang, Qian Guo, Yuchen Zheng, Jia Shi, Jijun Wang, Guanjun Li, Chunbo Li, John A Fromson, Yong Xu, Xiaohua Liu, Hua Xu, Tianhong Zhang, Yunfei Lu, Xiaorong Chen, Hao Hu, Yingying Tang, Shuwen Yang, Han Zhou, Xiaoliang Wang, Haiying Chen, Zhen Wang, Zongguo Yang

Abstract

Since the end of 2019, Corona Virus Disease 2019 (COVID-19) has been the cause of a worldwide pandemic. The mental status of patients with COVID-19 who have been quarantined and the interactions between their psychological distress and physiological levels of inflammation have yet to be analyzed. Using a mixed-method triangulation design (QUAN + QUAL), this study investigated and compared the mental status and inflammatory markers of 103 patients who, while hospitalized with mild symptoms, tested positive with COVID-19 and 103 matched controls that were COVID-19 negative. The severity of depression, anxiety, and post-traumatic stress symptoms (PTSS) was measured via an on-line survey. Using a convenience sampling technique, qualitative data were collected until the point of data saturation. In addition, a semi-structured interview was conducted among five patients with COVID-19. Peripheral inflammatory markers were also collected in patients, both at baseline and within ± three days of completing the on-line survey. Results revealed that COVID-19 patients, when compared to non-COVID controls, manifested higher levels of depression (P < 0.001), anxiety (P < 0.001), and post-traumatic stress symptoms (P < 0.001). A gender effect was observed in the score of "Perceived Helplessness", the subscale of PSS-10, with female patients showing higher scores compared to male patients (Z = 2.56, P = 0.010), female (Z = 2.37, P = 0.018) and male controls (Z = 2.87, P = 0.004). Levels of CRP, a peripheral inflammatory indicator, correlated positively with the PHQ-9 total score (R = 0.37, P = 0.003, Spearman's correlation) of patients who presented symptoms of depression. Moreover, the change of CRP level from baseline inversely correlated with the PHQ-9 total score (R = -0.31, P = 0.002), indicative of improvement of depression symptoms. Qualitative analysis revealed similar results with respect to patient reports of negative feelings, including fear, guilt, and helplessness. Stigma and uncertainty of viral disease progression were two main concerns expressed by COVID-19 patients. Our results indicate that significant psychological distress was experienced by hospitalized COVID-19 patients and that levels of depressive features may be related to the inflammation markers in these patients. Thus, we recommend that necessary measures should be provided to address depression and other psychiatric symptoms for COVID-19 patients and attention should be paid to patient perceived stigma and coping strategies when delivering psychological interventions.

Keywords: COVID-19; Depression; Mixed-method; Peripheral inflammation; Stress.

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Copyright © 2020 Elsevier Inc. All rights reserved.

Figures

Fig. 1
Fig. 1
The distributions presenting the total scores of PHQ-9, GAD-7, PSS-10, PCL-5, stratified by genders. The aroids represent that there are significant between-group differences.
Fig. 2
Fig. 2
The boxplot of the score of PSS-10 subscale “Perceived Helplessness” between two groups, split by gender. The aroids represent statistical difference between subgroups.
Fig. 3
Fig. 3
Spearman’s rank correlation coefficient analysis correlating the total score of PHQ-9 and the level of CRP among COVID-19 patients with symptoms of depression.

References

    1. Arabi Y.M., Harthi A., Hussein J., Bouchama A., Johani S., Hajeer A.H., Saeed B.T., Wahbi A., Saedy A., AlDabbagh T., Okaili R., Sadat M., Balkhy H. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43:495–501. doi: 10.1007/s15010-015-0720-y.
    1. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 1999;160:1–12. doi: 10.1677/joe.0.1600001.
    1. Barbosa-Leiker C., Kostick M., Lei M., McPherson S., Roper V., Hoekstra T., Wright B. Measurement invariance of the perceived stress scale and latent mean differences across gender and time. Stress Health. 2013;29:253–260. doi: 10.1002/smi.2463.
    1. Besedovsky H.O., Del Rey A., Klusman I., Furukawa H., Monge Arditi G., Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 1991;40:613–618. doi: 10.1016/0960-0760(91)90284-C.
    1. Bo H.X., Li W., Yang Y., Wang Y., Zhang Q., Cheung T., Wu X., Xiang Y.T. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol. Med. 2020;1–7 doi: 10.1017/S0033291720000999.
    1. Brietzke E., Magee T., Freire R.C.R., Gomes F.A., Milev R. Three insights on psychoneuroimmunology of mood disorders to be taken from the COVID-19 pandemic. Brain Behav. Immun. Health. 2020;5 doi: 10.1016/j.bbih.2020.100076.
    1. Chan J.F.-W., Yuan S., Kok K.-H., To K.K.-W., Chu H., Yang J., Xing F., Liu J., Yip C.C.-Y., Poon R.W.-S., Tsoi H.-W., Lo S.K.-F., Chan K.-H., Poon V.K.-M., Chan W.-M., Ip J.D., Cai J.-P., Cheng V.C.-C., Chen H., Hui C.K.-M., Yuen K.-Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi: 10.1016/S0140-6736(20)30154-9.
    1. Cheng S.K., Wong C.W., Tsang J., Wong K.C. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS) Psychol. Med. 2004;34:1187–1195. doi: 10.1017/S0033291704002272.
    1. Cheng Z.J., Shan J. 2019 Novel coronavirus: where we are and what we know. Infection. 2020;48:155–163. doi: 10.1007/s15010-020-01401-y.
    1. China, N.H.C.o.T.P.s.R.o., 2020. Diagnosis and Management Program of Novel Coronavirus-infected Pneumonia, fourth ed. . (Accessed 8 May 2020).
    1. Chua S.E., Cheung V., McAlonan G.M., Cheung C., Wong J.W., Cheung E.P., Chan M.T., Wong T.K., Choy K.M., Chu C.M., Lee P.W., Tsang K.W. Stress and psychological impact on SARS patients during the outbreak. Can. J. Psychiatry. 2004;49:385–390. doi: 10.1177/070674370404900607.
    1. Giacomelli A., Pezzati L., Conti F., Bernacchia D., Siano M., Oreni L., Rusconi S., Gervasoni C., Ridolfo A.L., Rizzardini G., Antinori S., Galli M. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa330.
    1. Gold P.W., Licinio J., Wong M.L., Chrousos G.P. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann. N. Y. Acad. Sci. 1995;771:716–729. doi: 10.1111/j.1749-6632.1995.tb44723.x.
    1. Golden-Kreutz D.M., Browne M.W., Frierson G.M., Andersen B.L. Assessing Stress in Cancer Patients: A Second-Order Factor Analysis Model for the Perceived Stress Scale. Assessment. 2004;11:216–223. doi: 10.1177/1073191104267398.
    1. Guetterman T.C., Fetters M.D., Creswell J.W. Integrating Quantitative and Qualitative Results in Health Science Mixed Methods Research Through Joint Displays. Ann. Fam. Med. 2015;13:554–561. doi: 10.1370/afm.1865.
    1. Kim S.W., Su K.P. Using psychoneuroimmunity against COVID-19. Brain Behav. Immun. 2020 doi: 10.1016/j.bbi.2020.03.025.
    1. Köhler C.A., Freitas T.H., Maes M., de Andrade N.Q., Liu C.S., Fernandes B.S., Stubbs B., Solmi M., Veronese N., Herrmann N., Raison C.L., Miller B.J., Lanctôt K.L., Carvalho A.F. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta. Psychiatr. Scand. 2017;135:373–387. doi: 10.1111/acps.12698.
    1. Koopman C., Classen C., Cardeña E., Spiegel D. When disaster strikes, acute stress disorder may follow. J. Trauma. Stress. 1995;8:29–46. doi: 10.1007/BF02105405.
    1. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Kuhlman K.R., Robles T.F., Dooley L.N., Boyle C.C., Haydon M.D., Bower J.E. Within-subject associations between inflammation and features of depression: Using the flu vaccine as a mild inflammatory stimulus. Brain Behav. Immun. 2018;69:540–547. doi: 10.1016/j.bbi.2018.02.001.
    1. Lai J., Ma S., Wang Y., Cai Z., Hu J., Wei N., Wu J., Du H., Chen T., Li R., Tan H., Kang L., Yao L., Huang M., Wang H., Wang G., Liu Z., Hu S. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw. Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.3976.
    1. Lee S., Chan L.Y., Chau A.M., Kwok K.P., Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Soc. Sci. Med. 2005;61:2038–2046. doi: 10.1016/j.socscimed.2005.04.010.
    1. Li J., Zhang W., Chen W., Yuan H., Zhang S., Tian M., Qu Z. Applications of the Chinese version of the primary care PTSD screen for DSM-5 (PC-PTSD-5) for children. J. Affect. Disord. 2019;254:109–114. doi: 10.1016/j.jad.2019.05.021.
    1. Li Z., Ge J., Yang M., Feng J., Qiao M., Jiang R., Bi J., Zhan G., Xu X., Wang L., Zhou Q., Zhou C., Pan Y., Liu S., Zhang H., Yang J., Zhu B., Hu Y., Hashimoto K., Jia Y., Wang H., Wang R., Liu C., Yang C. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav. Immun. 2020 doi: 10.1016/j.bbi.2020.03.007.
    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S.M., Lau E.H.Y., Wong J.Y., Xing X., Xiang N., Wu Y., Li C., Chen Q., Li D., Liu T., Zhao J., Li M., Tu W., Chen C., Jin L., Yang R., Wang Q., Zhou S., Wang R., Liu H., Luo Y., Liu Y., Shao G., Li H., Tao Z., Yang Y., Deng Z., Liu B., Ma Z., Zhang Y., Shi G., Lam T.T.Y., Wu J.T.K., Gao G.F., Cowling B.J., Yang B., Leung G.M., Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020;382:1199–1207. doi: 10.1056/NEJMoa2001316.
    1. Li W., Lukai RongjingD., Dayi H., Sheng L. GW25-e4488 The value of Chinese version GAD-7 and PHQ-9 to screen anxiety and depression in cardiovascular outpatients. J. Am. Coll. Cardiol. 2014;64:C222. doi: 10.1016/j.jacc.2014.06.1038.
    1. Liu N., Zhang F., Wei C., Jia Y., Shang Z., Sun L., Wu L., Sun Z., Zhou Y., Wang Y., Liu W. Prevalence and predictors of PTSS during COVID-19 Outbreak in China Hardest-hit Areas: Gender differences matter. Psychiatry Res. 2020;287 doi: 10.1016/j.psychres.2020.112921.
    1. Mak I.W., Chu C.M., Pan P.C., Yiu M.G., Chan V.L. Long-term psychiatric morbidities among SARS survivors. Gen. Hosp. Psychiatry. 2009;31:318–326. doi: 10.1016/j.genhosppsych.2009.03.001.
    1. Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., Miao X., Li Y., Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.1127.
    1. Marques-Deak A., Cizza G., Sternberg E. Brain-immune interactions and disease susceptibility. Mol. Psychiatry. 2005;10:239–250. doi: 10.1038/sj.mp.4001643.
    1. Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., Ueno M., Sakata H., Kondo K., Myose N., Nakao A., Takeda M., Haro H., Inoue O., Suzuki-Inoue K., Kubokawa K., Ogihara S., Sasaki T., Kinouchi H., Kojin H., Ito M., Onishi H., Shimizu T., Sasaki Y., Enomoto N., Ishihara H., Furuya S., Yamamoto T., Shimada S. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55–58. doi: 10.1016/j.ijid.2020.03.062.
    1. National Health Commission of China, A notice on the issuance of guidelines for emergency psychological crisis intervention in pneumonia for novel coronavirus infections (in Chinese). . (Accessed 8 May 2020).
    1. Noone P. Flu, Q-fever-related absence and PTSD in reservists. Occup. Med. 2013;63 doi: 10.1093/occmed/kqt022. 311–311.
    1. Phan L.T., Nguyen T.V., Luong Q.C., Nguyen T.V., Nguyen H.T., Le H.Q., Nguyen T.T., Cao T.M., Pham Q.D. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. N. Engl. J. Med. 2020;382:872–874. doi: 10.1056/NEJMc2001272.
    1. Pluye P., Hong Q.N. Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annu. Rev. Public Health. 2014;35:29–45. doi: 10.1146/annurev-publhealth-032013-182440.
    1. Qiu J., Shen B., Zhao M., Wang Z., Xie B., Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen. Psychiatr. 2020;33 doi: 10.1136/gpsych-2020-100213.
    1. Roberti J.W., Harrington L.N., Storch E.A. Further Psychometric Support for the 10-Item Version of the Perceived Stress Scale. J. College Counsel. 2006;9:135–147. doi: 10.1002/j.2161-1882.2006.tb00100.x.
    1. Shafiee M., Tayefi M., Hassanian S.M., Ghaneifar Z., Parizadeh M.R., Avan A., Rahmani F., Khorasanchi Z., Azarpajouh M.R., Safarian H., Moohebati M., Heidari-Bakavoli A., Esmaeili H., Nematy M., Safarian M., Ebrahimi M., Ferns G.A., Mokhber N., Ghayour-Mobarhan M. Depression and anxiety symptoms are associated with white blood cell count and red cell distribution width: A sex-stratified analysis in a population-based study. Psychoneuroendocrinology. 2017;84:101–108. doi: 10.1016/j.psyneuen.2017.06.021.
    1. Siqueira Reis R., Ferreira Hino A.A., Rodriguez Añez Romélio C. Perceived stress scale: Reliability and validity study in Brazil. J. Health Psychol. 2010 doi: 10.1177/1359105309346343.
    1. Swendeman D., Fehrenbacher A.E., Roy S., Das R., Ray P., Sumstine S., Ghose T., Jana S. Gender disparities in depression severity and coping among people living with HIV/AIDS in Kolkata, India. PLoS One. 2018;13 doi: 10.1371/journal.pone.0207055.
    1. Team R.D.C. the R Foundation for Statistical Computing; Vienna, Austria: 2011. R: A language and environment for statistical computing.
    1. Troyer E.A., Kohn J.N., Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav. Immun. 2020 doi: 10.1016/j.bbi.2020.04.027.
    1. Tsai L.-K., Hsieh S.-T., Chang Y.-C. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol. Taiwan. 2005;14:113–119. doi: 10.29819/ANT.200509.0002.
    1. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 2013;150:736–744. doi: 10.1016/j.jad.2013.06.004.
    1. van Hoek A.J., Underwood A., Jit M., Miller E., Edmunds W.J. The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PloS One. 2011;6 doi: 10.1371/journal.pone.0017030.
    1. Wang J., Dunn A.J. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem. Int. 1998;33:143–154. doi: 10.1016/S0197-0186(98)00016-3.
    1. Wang W., Bian Q., Zhao Y., Li X., Wang W., Du J., Zhang G., Zhou Q., Zhao M. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen. Hosp. Psychiatry. 2014;36:539–544. doi: 10.1016/j.genhosppsych.2014.05.021.
    1. Wang Z., Chen J., Boyd J.E., Zhang H., Jia X., Qiu J., Xiao Z. Psychometric Properties of the Chinese Version of the Perceived Stress Scale in Policewomen. PloS One. 2011;6 doi: 10.1371/journal.pone.0028610.
    1. Wheaton M.G., Abramowitz J.S., Berman N.C., Fabricant L.E., Olatunji B.O. Psychological Predictors of Anxiety in Response to the H1N1 (Swine Flu) Pandemic. Cognit. Ther. Res. 2012;36:210–218. doi: 10.1007/s10608-011-9353-3.
    1. Whitlock F.A. The neurology of affective disorder and suicide. Aust. N. Z. J. Psychiatry. 1982;16:1–12. doi: 10.3109/00048678209159465.
    1. WHO, 2020. Naming the coronavirus disease (COVID-19) and the virus that causes it. (Accessed 8 May 2020).
    1. Wing, Y., Ho, M., 2004. Mental health of patients infected with SARS, in: In Challenges of Severe Acute Respiratory Syndrome. Elsevier, Hong Kong, pp. 526-546.
    1. Wortmann J.H., Jordan A.H., Weathers F.W., Resick P.A., Dondanville K.A., Hall-Clark B., Foa E.B., Young-Mccaughan S., Yarvis J.S., Hembree E.A. Psychometric Analysis of the PTSD Checklist-5 (PCL-5) Among Treatment-Seeking Military Service Members. Psychol. Assess. 2016;28:1392–1403. doi: 10.1037/pas0000260.
    1. Wu K.K., Chan S.K., Ma T.M. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS) J. Trauma. Stress. 2005;18:39–42. doi: 10.1002/jts.20004.
    1. Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Liu C., Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020 doi: 10.1016/j.bbi.2020.03.031.
    1. Xiang Y.T., Yang Y., Li W., Zhang L., Zhang Q., Cheung T., Ng C.H. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7:228–229. doi: 10.1016/S2215-0366(20)30046-8.
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W., China Novel Coronavirus I., Research T. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner